Neurological Conditions and Cannabis

The cannabinoids present in Medical Marijuana/Cannabis binds with these CB1 and CB2 receptors and aids in nervous system disorders by offering calming effect to the nervous system.

Experts are not 100% sure as to how these receptors react with cannabinoids and deliver therapeutic effects, but they believe that maybe it works by preventing endocannabinoids from being broken down.

While the research is still going on, people have reported that CBD has helped them in pain, nausea, and anxiety management.

The neurotransmitters and receptors in the endocannabinoid system mainly regulate functions like sleep, pain, immune system response , and appetite. There are anecdotal reports that show that CBD, which does not show psychoactive effects, has been effective in reducing seizures in some people with epilepsy.

For example, cannabidiol (CBD) has been extensively evaluated for its anti-seizure activity in various seizure models. These studies have discovered that CBD successfully reduces the occurrence of seizures that were induced by maximal electroshock.

Currently, a prescription drug CBD called Epidolex, is approved by the FDA (Food and Drug Administration) to treat Dravet and Lennox-Gastaut syndromes, two rare forms of epilepsy.

These medicines were approved after controlled clinical trials for epileptic seizures. Hence any treatment that has not undergone trials and contains an unregulated amount of THC can be harmful to patients.

Medical Marijuana/Cannabis can offer numerous benefits for neurological conditions, but its conclusive advantages and response to diseases need more research and scrutiny.